Trials / Not Yet Recruiting
Not Yet RecruitingNCT07463781
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy: a Multicenter Observational Prospective Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Fondazione Italiana Linfomi - ETS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational, multicenter, prospective cohort study including patients treated with CAR-T in Italian centers. Patients eligible for enrollment in the study will be consecutively included in Italian FIL centers. A longitudinal survey will be carried out by collecting patients' data before starting CAR-T (T0) and after 6 (T1), 12 (T2) and 24 (T3) months after CAR-T infusion.
Conditions
- Diffuse Large B Cell Lymphoma (DLBCL)
- High Grade B Cell Lymphoma
- Primary Mediastinal B-cell Lymphoma (PMBCL)
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Chimeric Antigen Receptor T-cells (CAR-T) therapy | Patients will be treated with CAR-T cell product as per routine clinical practice. |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2029-05-01
- Completion
- 2029-05-01
- First posted
- 2026-03-11
- Last updated
- 2026-03-13
Locations
8 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT07463781. Inclusion in this directory is not an endorsement.